PASCALE, RENATO
 Distribuzione geografica
Continente #
AS - Asia 3.399
NA - Nord America 2.724
EU - Europa 2.357
SA - Sud America 257
AF - Africa 201
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.964
Nazione #
US - Stati Uniti d'America 2.648
SG - Singapore 1.167
CN - Cina 1.127
IT - Italia 930
VN - Vietnam 342
DE - Germania 293
SE - Svezia 281
HK - Hong Kong 236
KR - Corea 220
GB - Regno Unito 183
BR - Brasile 174
IN - India 138
NL - Olanda 123
IE - Irlanda 104
RU - Federazione Russa 88
CI - Costa d'Avorio 82
FR - Francia 78
FI - Finlandia 65
CA - Canada 51
BG - Bulgaria 44
JP - Giappone 43
TG - Togo 36
AR - Argentina 35
AT - Austria 34
JO - Giordania 32
ID - Indonesia 30
CH - Svizzera 25
NG - Nigeria 21
ZA - Sudafrica 21
AU - Australia 20
BE - Belgio 18
ES - Italia 15
MX - Messico 15
PL - Polonia 14
UA - Ucraina 14
EC - Ecuador 13
SC - Seychelles 13
TR - Turchia 11
CL - Cile 10
BD - Bangladesh 9
CO - Colombia 9
PK - Pakistan 9
RO - Romania 9
IQ - Iraq 7
EE - Estonia 5
IR - Iran 5
LT - Lituania 5
PE - Perù 5
TN - Tunisia 5
AL - Albania 4
DK - Danimarca 4
GR - Grecia 4
MA - Marocco 4
DZ - Algeria 3
HN - Honduras 3
HR - Croazia 3
KE - Kenya 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EG - Egitto 2
LB - Libano 2
LU - Lussemburgo 2
LY - Libia 2
MK - Macedonia 2
MY - Malesia 2
NE - Niger 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TH - Thailandia 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BZ - Belize 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MR - Mauritania 1
MU - Mauritius 1
NA - Namibia 1
NC - Nuova Caledonia 1
NP - Nepal 1
PG - Papua Nuova Guinea 1
Totale 8.957
Città #
Singapore 802
Hefei 494
Ashburn 426
Chandler 317
Hong Kong 234
Seoul 211
Bologna 186
Santa Clara 157
Southend 125
Dallas 117
Beijing 108
Fairfield 107
Dublin 104
Ho Chi Minh City 99
Milan 87
Abidjan 82
Hanoi 81
Princeton 80
Boardman 76
Ann Arbor 68
Los Angeles 65
New York 59
Wilmington 51
Bengaluru 48
Woodbridge 46
Bremen 44
Florence 44
Houston 44
Seattle 43
Sofia 43
Rome 41
Munich 40
Helsinki 36
Lomé 36
Tokyo 36
Redondo Beach 33
Amman 32
Turin 31
Berlin 28
Vienna 26
Jakarta 23
Buffalo 22
Cambridge 22
Shanghai 22
São Paulo 22
Bern 21
Frankfurt am Main 21
Lappeenranta 19
Nuremberg 19
Victoria 18
Abeokuta 17
Brussels 17
Redmond 17
Amsterdam 16
Chicago 16
Des Moines 15
Falkenstein 15
Redwood City 15
Toronto 15
Tongling 14
Jinan 13
London 13
Castel Maggiore 12
Denver 12
Westminster 12
Ha Long 11
The Dalles 11
Washington 11
Adelaide 10
Boydton 10
Da Nang 10
Ferrara 10
Johannesburg 10
Orem 10
Padova 10
Stockholm 10
Turku 10
Duncan 9
Haiphong 9
Modena 9
Parma 9
Quận Bình Thạnh 9
Bühl 8
Genoa 8
Guangzhou 8
Mexico City 8
Montreal 8
Nanjing 8
Naples 8
Paris 8
Saint Petersburg 8
San Diego 8
Verona 8
Yubileyny 8
Bogotá 7
Boston 7
Brooklyn 7
Catania 7
Cesena 7
Changsha 7
Totale 5.521
Nome #
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 234
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 210
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 210
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 210
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 204
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 203
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 201
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 196
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 191
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 187
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 181
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 174
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 166
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 161
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 161
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 152
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 151
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 146
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 143
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 143
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 141
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 136
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 136
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 135
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 133
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 131
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 130
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 123
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 122
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 122
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized with COVID-19 Pneumonia: A Randomized Clinical Trial 122
‘Treatment duration for Escherichia coli bloodstream infection and outcomes’ – Author's reply 120
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review 119
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 119
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections 117
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature 116
CMV-RNAemia as new marker of active viral replication in transplant recipients 116
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 116
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 115
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 114
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 114
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study 113
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 113
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 112
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 111
The Role of Microbes in Surgical Decision Making for Infective Endocarditis: Mitral Valve Repair or Replacement? 109
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 109
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicenter observational study (CarDINe Study) 106
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 106
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences 100
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 98
Infections Management in the Lung Transplant Setting in Italy: A Web-Survey 96
Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots 96
Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature 94
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 92
null 91
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 86
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 84
Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies 83
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 81
null 78
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 76
Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature 75
Epidemiology and antibiotic resistance in a large italian teaching hospital 75
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 72
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in solid organ transplant recipients 68
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 65
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 61
Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study 58
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful? 56
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 53
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 51
Prognostic role of aetiological agent vs. clinical pattern in candidates to lead extraction for cardiac implantable electronic device infections 51
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study 43
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection 41
Intestinal helminths in immigrants in Naples (Italy): A comparison between two different diagnostic techniques 39
Sphingomonas paucimobilis osteomyelitis in an immunocompetent patient. A rare case report and literature review 37
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 31
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections 30
Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot 27
Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort study 27
SARS-CoV-2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS 22
Totale 9.237
Categoria #
all - tutte 27.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 0 0 0 23 20 29 55 57 24 87
2021/2022810 18 10 25 77 63 41 26 54 78 113 181 124
2022/20231.346 89 161 61 191 106 122 35 104 255 48 103 71
2023/2024656 72 69 33 60 46 100 31 36 35 61 50 63
2024/20252.342 87 199 210 218 274 129 168 92 64 201 232 468
2025/20263.391 625 811 581 582 545 247 0 0 0 0 0 0
Totale 9.237